Value of D-dimer, C-reactive protein, procalcitonin, and blood routine test in assessing the prognosis of severe coronavirus disease 2019

Abstract

Objective: To investigate the value of D-dimer, C-reactive protein (CRP), Procalcitonin (PCT) and blood routine test in evaluating the prognosis of patients with severe coronavirus disease 2019 (COVID-19) Methods: A total of 54 severe COVID-19 patients were retrospectively studied, and were divided into death group (n=54) and survival group (n=31) according to the outcomes The plasma D-dimer, CRP, PCT, and blood routine test of the two groups were analyzed and compared in order to clarify their relationship to the prognosis of severe COVID-19 Results: The time to initiation of disease days, age and proportion of comorbidity in death group were significantly longer or higher than in survival group (all P0 05) Conclusion: D-dimer, CRP, white blood cell counts, and lymphocyte counts are valuable for prognosis evaluation of patients with severe COVID-19, and PCT also has certain prognostic value © 2021, Editorial Board of Medical Journal of Wuhan University All right reserved